Search By Initial

Name Index C

• CB1-IN-1 (Catalog# : 6111108, Cas# : 1429239-98-4)CB1-IN-1 is a peripherally restricted CB1R antagonist, with Ki of 0.3 nM and 21 nM fo
• Coelenterazine (Catalog# : 6111016, Cas# : 55779-48-1)Coelenterazine
• 1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine (Catalog# : 61110004, Cas# : 1228780-72-0)1-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazine
• CC0651 (Catalog# : 611933, Cas# : 1319207-44-7)CC0651 is an allosteric inhibitor of the human cdc34 ubiquitin-conjugating enzyme tha
• CDKI-73 (Catalog# : 611920, Cas# : 1421693-22-2)CDKI-73 is a potent CDK9 inhibitor with Ki of 4 nM; shows selective toxicity to CLL c
• CDK9-IN-6 (Catalog# : 611919, Cas# : 1391855-95-0)CDK9-IN-6 is a CDK9 inhibitor, refers to Example 399 in WO 2012101062 A1
• Ca2+ channel agonist 1 (Catalog# : 611918, Cas# : 1402821-24-2)Ca2+ channel agonist 1 is a N-type Ca2+ channel activity agonist, with EC50 of 14.23
• CX-4945 sodium salt (Catalog# : 611912, Cas# : 1309357-15-0)CX-4945 (Silmitasertib) sodium salt is a potent and selective ATP-competitive small m
• CAL-130 Racemate (Catalog# : 611824, Cas# : 474012-90-3)CAL-130 racemate is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reporte
• CAL-130 Hydrochloride (Catalog# : 611823, Cas# : 1431697-78-7)CAL-130 Hcl is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported tha
• CAL-130 (Catalog# : 611822, Cas# : 1431697-74-3)CAL-130 is a novel phosphoinositide 3-kinase (PI3K) inhibitor. It is reported that co
• Compound 401 (Catalog# : 611816, Cas# : 168425-64-7)Compound 401 is a synthetic inhibitor of DNA-PK (IC50 = 0.28 M) that also targets mTO
• CC-115 hydrochloride (Catalog# : 611815, Cas# : 1300118-55-1)CC-115 hydrochloride is a inhibitor of mTOR/DNA-PK (IC50= 21/ 13 nM). CC-115 shows go
• 3 CAI (Catalog# : 611801, Cas# : 28755-03-5)3CAI is a potent allosteric and specific AKT inhibitor, which exerts efficacy in vitr
• Chrysophanic acid (Catalog# : 161009017, Cas# : 481-74-3)Chrysophanic acid preferentially blocked proliferation in SNU-C5 cells but not in oth
• CAY10505 (Catalog# : 160926016, Cas# : 1218777-13-9)CAY10505 is a phosphatidylinositol 3-kinase- inhibitor , was found to significantly i
• CH5132799 (PA-799) (Catalog# : 160926015, Cas# : 1007207-67-1)CH5132799, also known as PA-799, is a novel class I PI3K inhibitor, which exhibited a
• CCT245737 (Catalog# : 16090101, Cas# : 1489389-18-5)CCT245737(CCT-245737, CAS 1489389-18-5) is the first orally active, clinical developm
• CWHM-12 (Catalog# : 16071407, Cas# : 1564286-55-0)vitro ligand-binding assays, with somewhat less potency against v5 than against the o
• CMK (Catalog# : 16071401, Cas# : 821794-90-5)CMK
• Copanlisib (Catalog# : 16070917, Cas# : 1032568-63-0)Copanlisib, also known as BAY 80-6946, is a phosphoinositide 3-kinase (PI3K) inhibito
• CCT244747 (Catalog# : 16070913, Cas# : 1404095-34-6)CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inh
• CP-673451 (Catalog# : 16070704, Cas# : 343787-29-1)CP-673451 is a selective inhibitor of PDGFR/ with IC50 of 10 nM/1 nM in cell-free ass
• CHIR-99021 (Catalog# : 16062904, Cas# : 252917-06-9)CHIR-99021, also known as CT99021, is a glycogen synthase kinase 3 (GSK3) inhibitor t
• CA-074 (Catalog# : 16062115, Cas# : 134448-10-5)CA-074
• CF-102 (Catalog# : 16053104, Cas# : 163042-96-4)CF-102, also known as 2-Cl-IB-MECA, is an orally bioavailable, synthetic, highly sele
• CHIR-090 (Catalog# : SSC65304, Cas# : 728865-23-4)CHIR-090 is a potent LpxC inhibitor, displays two-step time-dependent inhibition and
• 4-cyclopropylphenylacetic acid (Catalog# : 032509, Cas# : 40641-90-5)Coming soon!
• 2-Chloro-3-fluoro-4-(trifluoromethyl)pyridine (Catalog# : 032506, Cas# : 628692-22-8)Coming soon!
• CEP-1347 (Catalog# : 032402, Cas# : 156177-65-0)Coming soon!